April 13 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc's VRX.N VRX.TO outgoing Chief Executive Michael Pearson (LON:PSON)
will depose before the Senate Special Committee on Aging to
comply with a congressional subpoena, the committee said.
Pearson will depose on April 18, ahead of an April 27
hearing, the committee said in a statement on Wednesday.
Valeant said on Monday that it had asked Pearson to
cooperate with the committee after he failed to show up at a
hearing on Friday related to an investigation into drug pricing.